Saudi Arabia reports fatal MERS case
Saudi Arabia s Ministry of Health (MOH) today reported a new MERS-CoV case, which involves a 36-year-old man who died from his infection.
The man was from Hafr Al-Batin in the country s northeast. An investigation found that the man had been exposed to camels. He wasn t a healthcare worker and isn t thought to have contracted MERS-CoV (Middle East respiratory syndrome coronavirus) from another person.
The case marks Saudi Arabia s eighth of the year. The World Health Organization (WHO) said in an April update that, since 2012 when virus was first detected in humans, it has received reports of 2,574 confirmed cases, at least 886 of them fatal.
It looks like this was the result of either:
A mistyped address
A broken link on our site
A broken link on a search engine results page
A broken link on someone else s page
Some things to try:
Use the navigation menu at the top Most Read
SHARE
Saudi Arabia’s Ministry of Health has eased public concern after announcing a delay in second doses of Covid-19 vaccines on April 10.
The Health Ministry said on its Twitter page that a lack of global supply was the cause for a delay in second doses, which would be rescheduled as soon as possible.
It said concerns raised by the public about the delay were incorrect and that there was no cause for concern.
“The postponement was due to a lack of global supply, and for the largest possible number of members of the community to benefit from the doses available and achieve immunity provided by immunisation, the ministry said.
JEDDAH: Saudi Arabia’s Ministry of Health has refuted claims on social media that people waiting for their second doses will not receive them due to concerns about side effects.
On its Twitter account, the ministry published one of the most disputed claims circulating on various platforms on Sunday, reassuring residents that there was no cause for concern. It posted one of the FAQs, saying: “Incorrect, the postponement was due to lack of global supply, and in order for the largest possible number of members of the community to benefit from (the doses available) to achieve the immunity provided by immunization. Quantities will be provided and rescheduled for the second dose.”